Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

ART Safety Considerations in Aging Patients With HIV

Source: State of the ART: Applying Up-to-Date Safety and Tolerability Data to Individualize HIV Care
Hear from experts about their approach to caring for older patients with HIV, including deprescribing ARV and non-ARV medications to address polypharmacy and other geriatric syndromes.
Marta Boffito, MD, PhD, FRCP
Julian Falutz, MD, FRCPC
Released: November 2, 2022

In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including:

  • Consequences of polypharmacy
  • Deprescribing ARV and non-ARV medications
  • Complications associated with aging (eg, geriatric syndromes such as falls, frailty, multimorbidity)
  • Mediations to avoid, such as anticholinergic medications, to minimize drug–drug interactions and risk of developing geriatric syndromes

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Information on this Educational Activity

Faculty

Marta Boffito, MD, PhD, FRCP

Consultant Physician/Professor
HIV/Research
Chelsea and Westminster Hospital
Imperial College London
London, United Kingdom

Marta Boffito, MD, PhD, FRCP: consultant/advisor/speaker: Cipla, Gilead Sciences, GlaxoSmithKline, Janssen, Merck Sharpe and Dohme, ViiV Healthcare; researcher: Novavax, Roche, Valneva.
Julian Falutz, MD, FRCPC

Associate Professor of Medicine
Department of Medicine
McGill University School of Medicine
Director
Comprehensive HIV and Aging Initiative
Chronic Viral Illness Service
McGill
Montreal, Quebec, Canada

Julian Falutz, MD, FRCPC:consultant/advisor/speaker: Gilead Sciences, Merck, ViiV Healthcare.

Program Medium

This program has been made available online.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings